You remember that a relative had thyroid cancer, but you aren't sure what kind. Then a medication questionnaire asks about a family history, and the distinction suddenly feels important.
It is. Thyroid cancer isn't a single diagnosis, and some medication precautions refer to a specific type called medullary thyroid carcinoma, or MTC. If you don't know the type in your family, tell the prescriber what you do know and ask how to clarify it. Don't guess from a relative's treatment or from a search result.
The specific history your prescriber needs
Wegovy, a semaglutide product, and Zepbound, a tirzepatide product, should not be used by people with a personal or family history of MTC or by people with multiple endocrine neoplasia syndrome type 2, often called MEN2. Your prescriber needs to know if either applies to you.
If you're already taking one of these medicines and learn of such a history, contact your prescriber promptly, before your next dose, for specific guidance. If you're considering treatment, share the information before starting. The care team can discuss other options with you.
This article discusses two specific products as examples. Other medicines and formulations have their own information. Give your clinician the exact name and form of the product you're asking about rather than assuming every label is identical.
Thyroid cancer can mean more than one thing
MTC begins in a different type of thyroid cell from some other thyroid cancers. Other names you may hear include papillary and follicular thyroid cancer. A relative's statement that they had “thyroid cancer” doesn't tell you which type it was.
That difference matters for the specific MTC family-history precaution, but it doesn't mean you should decide that another thyroid diagnosis is irrelevant. Tell the prescriber about your own thyroid history and any family history you know. They can interpret the details in the context of the product and your health.
A thyroid nodule, an underactive thyroid, a thyroid operation, and a cancer diagnosis are also different pieces of information. Don't assume one proves or rules out another. If you're unsure what a relative was diagnosed with, “I don't know the type” is a useful and honest answer.
What is MEN2?
MEN2 is an inherited condition associated with an increased risk of MTC and certain other tumors. Some families may know the name from genetic counseling or a relative's medical records; others may not. Not every person with MTC has the same family history, and an unfamiliar term on its own is not a diagnosis.
If you've been told that you or a family member has MEN2, share that directly with the prescriber. If a relative mentions an inherited thyroid-cancer condition but you don't know its name, share that uncertainty too. Your clinician can help determine what information would be useful and whether another specialist should be involved.
You don't have to interpret a genetic test yourself or ask relatives to share private information they don't want to discuss. If appropriate, a clinician or genetic counselor can explain the next steps for your situation.
Why is the warning there?
In studies of rodents, semaglutide and tirzepatide caused thyroid C-cell tumors. It remains unknown whether these medicines cause those tumors, including MTC, in humans. An animal finding does not prove the same effect occurs in people; the uncertainty is part of the reason the specific family and personal history matters in prescribing decisions.
You may see headlines that state either “these medicines cause thyroid cancer” or “there is no concern.” Both skip important context. The animal findings, uncertainty in humans, and product-specific instructions all belong in the conversation.
Ask your prescriber to explain how the information applies to the exact medicine you're considering. Don't use a general article to decide on testing, treatment, or a medication change for yourself.
What if the family details are hard to find?
Start with what you know: which relative was affected, whether the diagnosis was thyroid cancer or another condition, and approximately when you heard about it. If you're comfortable asking and your relative is willing to share, the diagnosis name on a pathology report or visit summary may be more useful than a remembered description of surgery.
You can say: “I know my aunt had thyroid cancer, but I don't know the type. What should I do before deciding about this medication?” The clinician can tell you whether to obtain more information and how to proceed while the history is unclear.
If you have new symptoms such as a lump in the neck, persistent hoarseness, or difficulty swallowing, tell a clinician. Seek emergency care right away for trouble breathing or another severe symptom. These symptoms can have several causes, so they need assessment rather than a self-diagnosis.
Bring the conversation back to your care
Take your medication list and any records you have, but don't delay contacting the prescriber because the family history isn't complete. Ask what is known, what remains uncertain, and which treatment options are appropriate for you.
Knowing the exact diagnosis can make the conversation more useful. When the answer isn't available, saying so is the right place to start.










